Histone deacetylation may play a role in promoting E/M phenotypes; in breast cancer cells, the inhibition of histone deacetylation promotes hybrid E/M phenotypes indicated by the co-expression of E-cadherin and N-cadherin [48]. This evidence concerns the gene CDH2 and breast cancer.